Weight by Height
Conditions
Interventions
This is a two-arm, double-blind, randomized controlled clinical trial. The population of the present study will consist of older adults of both sexes living with type 2 diabetes (T2DM), aged between 6
Sponsors
Universidade São Judas Tadeu
Instituto de Ortopedia e Traumatologia do Hospital das Clínica da Faculdade de Medicina da Universidade de São Paulo
Eligibility
Sex/Gender
Male
Age
65 Years to 79 Years
Inclusion criteria
Inclusion criteria: Elderly participants with type 2 diabetes mellitus; aged between 65 and 79 years; male; on a stable dose of medication (oral antidiabetics, insulin, or a combination of both) for three or more months; glycated hemoglobin between 6% and 10.0%; without renal function impairment, which will be assessed using the Modification of Diet in Renal Disease (MDRD) formula, including only those with values above 60 ml/min; without musculoskeletal system impairment, pain, or any disabling disease or previous surgeries that prevent exercise; without inadequately treated or decompensated chronic non-communicable diseases, especially systemic arterial hypertension; with cognitive function within the normal range; assessed by the MoCA; considering cutoff scores according to the participant's educational level
Exclusion criteria
Exclusion criteria: Inability to undergo assessments and reassessments; having more than three absences during the training period; experiencing any adverse events related to musculoskeletal pain or worsening of symptoms or signs of pre-existing diseases; particularly changes in systemic blood pressure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A reduction in glycated hemoglobin (HbA1c) levels is expected, with a decrease of at least 0.5% after 12 weeks of intervention. The variable will be assessed through laboratory testing, performed one week before the start and one week after the end of the intervention. The objective is to compare the groups to evaluate the effects of the poliprotective strategy (dietary counseling, whey protein supplementation, and combined exercise) on the metabolic control of older adults with type 2 diabetes mellitus. | — |
Secondary
| Measure | Time frame |
|---|---|
| An improvement in physical performance is expected after 12 weeks of intervention, assessed through a battery of functional tests. These include handgrip strength (in kg/f), the Short Physical Performance Battery (SPPB) — total score ranging from 0 to 12, comprising balance, gait speed, and chair stand tests (in seconds), the Timed Up and Go (TUG) test with and without a cognitive task (in seconds), and the Senior Fitness Tests: upper and lower limb flexibility (in centimeters), upper and lower limb strength (number of repetitions), mobility (in seconds), and the 6-minute walk test (in meters). Data will be collected one week before the intervention and one week after its completion. | — |
Countries
Brazil
Contacts
Public ContactJoselma dos Santos
Universidade São Judas Tadeu
Outcome results
None listed